These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 18343577

  • 1. HSPA5 promoter polymorphisms and risk of Parkinson's disease in Taiwan.
    Chen CM, Wu YR, Hu FJ, Chen YC, Chuang TJ, Cheng YF, Lee-Chen GJ.
    Neurosci Lett; 2008 Apr 25; 435(3):219-22. PubMed ID: 18343577
    [Abstract] [Full Text] [Related]

  • 2. Functional polymorphisms of HSPA5: possible association with bipolar disorder.
    Kakiuchi C, Ishiwata M, Nanko S, Kunugi H, Minabe Y, Nakamura K, Mori N, Fujii K, Umekage T, Tochigi M, Kohda K, Sasaki T, Yamada K, Yoshikawa T, Kato T.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1136-43. PubMed ID: 16168956
    [Abstract] [Full Text] [Related]

  • 3. Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer's disease.
    Hsu WC, Wang HK, Lee LC, Fung HC, Lin JC, Hsu HP, Wu YR, Ro LS, Hu FJ, Chang YT, Lee-Chen GJ, Chen CM.
    J Neural Transm (Vienna); 2008 Nov 04; 115(11):1537-43. PubMed ID: 18781276
    [Abstract] [Full Text] [Related]

  • 4. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.
    Neurosci Lett; 2006 Sep 25; 405(3):202-6. PubMed ID: 16876320
    [Abstract] [Full Text] [Related]

  • 5. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P, Afsharinejad Z, Kelada SN, Costa LG, Franklin GM, Swanson PD, Longstreth WT, Viernes HM, Farin FM, Smith-Weller T, Checkoway H.
    Mov Disord; 2004 Jan 25; 19(1):76-83. PubMed ID: 14743364
    [Abstract] [Full Text] [Related]

  • 6. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
    Das G, Misra AK, Das SK, Ray K, Ray J.
    Neurosci Lett; 2009 Aug 21; 460(1):16-20. PubMed ID: 19450659
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms and haplotype structures of HSPA5 gene in the Han population of Southern China.
    Zhu X, Cheng J, Zhao J, Chen L, Hou S, Zhao G, Lan F, Wang W, Kung H, He M.
    Tissue Antigens; 2009 Nov 21; 74(5):420-3. PubMed ID: 19845896
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S, Hagenah J, Lincoln S, Heckman M, Haugarvoll K, Lohmann-Hedrich K, Kostic V, Farrer M, Klein C.
    Neurology; 2007 Oct 30; 69(18):1745-50. PubMed ID: 17872362
    [Abstract] [Full Text] [Related]

  • 11. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
    Kobayashi H, Ujike H, Hasegawa J, Yamamoto M, Kanzaki A, Sora I.
    Mov Disord; 2006 Dec 30; 21(12):2157-64. PubMed ID: 17078049
    [Abstract] [Full Text] [Related]

  • 12. The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.
    Rife T, Rasoul B, Pullen N, Mitchell D, Grathwol K, Kurth J.
    J Neurosci Res; 2009 Aug 01; 87(10):2319-25. PubMed ID: 19326438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J, Eerola J, Hellström O, Tienari PJ, Singleton A.
    Neurosci Lett; 2004 Sep 02; 367(2):168-70. PubMed ID: 15331145
    [Abstract] [Full Text] [Related]

  • 15. Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.
    Parsian A, Sinha R, Racette B, Zhao JH, Perlmutter JS.
    Parkinsonism Relat Disord; 2004 Jun 02; 10(4):213-9. PubMed ID: 15120095
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
    Huerta C, Alvarez V, Mata IF, Coto E, Ribacoba R, Martínez C, Blázquez M, Guisasola LM, Salvador C, Lahoz CH, Peña J.
    Neurosci Lett; 2004 Nov 11; 370(2-3):151-4. PubMed ID: 15488313
    [Abstract] [Full Text] [Related]

  • 19. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
    Lin JJ, Chen CH, Yueh KC, Chang CY, Lin SZ.
    Parkinsonism Relat Disord; 2006 Jan 11; 12(1):9-13. PubMed ID: 16337421
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.